3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
3
Rectal Neoplasms
2
Neoplasms
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Radiation Injuries
1
Prostatic Neoplasms
1
Postoperative Complications
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Melanoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Low Anterior Resection Syndrome
1
Liposarcoma
1
Leiomyosarcoma
1
Hepatic Veno-Occlusive Disease
1
Head and Neck Neoplasms
1
Fatigue
1
Interventions
Imatinib Mesylate
4
Sunitinib
3
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
trastuzumab deruxtecan
1
ripretinib
1
pemigatinib
1
Surgical Instruments
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Ipilimumab
1
IDRX-42
1
CTLA-4 Antigen
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Surgical Procedures, Operative
×
30 days
×
Clear all
No trials found.